Codexis Collaborates With Leading Biopharmaceutical Company to Apply CodeEvolver Protein Engineering in Therapeutics Development Program
Go back to Codexis Collaborates With Leading Biopharmaceutical Company to Apply CodeEvolver Protein Engineering in Therapeutics Development Program| CODEXIS (NASDAQ: CDXS) | Delayed: 2.39 +0.02 (0.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.37 | 52 Week High | $5.25 | |||
| Open | $2.33 | 52 Week Low | $2.93 | |||
| Day High | $2.44 | P/E | N/A | |||
| Day Low | $2.32 | EPS | $-1.25 | |||
| Volume | 396,288 | |||||

